• John Weinman, Imran Ali, Anna Hodgkinson, Martha Canfield, and Christina Jackson.
• Medicines Use Group, Institute of Pharmaceutical Sciences, Kings College London, London SE1 9NH, UK.
• Patient Prefer Adher. 2019 Jan 1; 13: 1895-1898.

ObjectiveOne of the challenges in being able to identify and manage medication adherence problems in routine practice is that patients are often reluctant to "admit to" non-adherence, particularly when asked in a direct way. The study reported in this paper has been designed as part of an attempt to address this problem by examining the value of a new brief medicines use screener in helping patients to identify and discuss adherence issues in a clinical setting.Methods145 Patients with type 2 diabetes completed the new screener (MMWFU) together with an adherence self-report scale (MMAS4) and medication beliefs questionnaire (BMQ). Correlations between the scales were assessed together with an assessment of the sensitivity and specificity of the new screener.Results126 (88%) of the sample identified at least one medicines-related issue on the MMWFU, which showed strong correlations with the MMAS4 and BMQ Concerns scales, as well as good sensitivity and specificity against the MMAS4.ConclusionThe results indicate that the new screener can serve as a fairly sensitive indicator of non-adherence and its determinants. Future studies will be needed to establish how well it performs in other clinical settings.© 2019 Weinman et al.

4 keywords...

hide…